Akt pathway evaluation by in situ immunofluorescence in non-small-cell lung cancer

被引:0
|
作者
Zheng, Zhong [1 ]
Haura, Eric [1 ]
Bepler, Gerold [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
D O I
10.1097/01.JTO.0000283277.90080.ff
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S402 / S402
页数:1
相关论文
共 50 条
  • [31] Immunotherapy for non-small-cell lung cancer
    Thomas, Anish
    Jakopovic, Marko
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (08) : 1061 - 1064
  • [32] LncRNAs in Non-Small-Cell Lung Cancer
    Ginn, Lucy
    Shi, Lei
    La Montagna, Manuela
    Garofalo, Michela
    [J]. NON-CODING RNA, 2020, 6 (03)
  • [33] Staging of Non-Small-Cell Lung Cancer
    Akhurst, Tim
    [J]. PET CLINICS, 2018, 13 (01) : 1 - +
  • [34] Cetuximab in non-small-cell lung cancer
    Pirker, Robert
    Filipits, Martin
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 54 - 60
  • [35] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    [J]. LANCET, 2001, 358 (9289): : 1270 - 1271
  • [36] Ifosfamide in non-small-cell lung cancer
    Rosell, R
    Martin, C
    Balaña, C
    [J]. ANNALS OF ONCOLOGY, 1999, 10 : 25 - 28
  • [37] Cancer vaccines for non-small-cell lung cancer
    Palma, M.
    Choudhury, A.
    Mellstedt, H.
    [J]. MINERVA CHIRURGICA, 2009, 64 (06) : 643 - 653
  • [38] Bevacizumab for non-small-cell lung cancer
    Garassino, Marina Chiara
    Hollander, Lital
    Torri, Valter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13): : 1373 - 1373
  • [39] Treatment of non-small-cell lung cancer
    Lavolé, A
    Blanchon, F
    Breton, JL
    Milleron, B
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 175 - 178
  • [40] Oligometastatic Non-Small-Cell Lung Cancer
    Palma, David A.
    Videtic, Gregory M. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 223 - 226